• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 190713
Device Problem Inadequate Ultra Filtration (1656)
Patient Problem Insufficient Information (4580)
Event Date 04/11/2024
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.  clinical review: based on the available information, the 2008t hemodialysis system can be disassociated from having a causal and/or contributory role in the adverse events experienced by the patient.There is no allegation or objective evidence indicating a serious injury, patient death, or other serious adverse event(s) related to a fresenius device(s) and/or product(s) deficiency or malfunction occurred.Furthermore, there was no report a fresenius device(s) and/or product(s) failed to meet the users¿ expectations or manufacturers¿ specifications.
 
Event Description
A user facility biomedical technician (biomed) reported to fresenius technical services that the ultrafiltration (uf) goal changed from 300 ml to 3000 ml with no staff intervention during the patient's hemodialysis (hd) treatment on the 2008t machine.It was reported the patient completed treatment without experiencing an adverse event, serious injury, or requiring medical intervention.Additional information was obtained during follow-up with the biomed and a user facility nurse.The nurse clarified that the issue resulted from operator error.The staff member who programmed the patient¿s treatment typed 300 ml instead of 3000 ml as the intended ultrafiltration (uf) goal.The error was not noted until treatment completion when the patient pulled the programmed 300 ml.The patient did not experience any symptoms or adverse events as a result of the reported issue.The patient returned to the clinic on a different day for an additional treatment to remove the fluid that was not taken in the original treatment.The biomed stated that the machine was removed from service for testing following the reported event.A simulated ultrafiltration (uf) treatment was completed without issue.No issues were identified and no parts were replaced.The machine has been released for service.No samples will be returned to the manufacturer for physical evaluation.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The complaint investigation did not find objective evidence indicating a product problem, thus the complaint is unconfirmed.
 
Event Description
A user facility biomedical technician (biomed) reported to fresenius technical services that the ultrafiltration (uf) goal changed from 300 ml to 3000 ml with no staff intervention during the patient's hemodialysis (hd) treatment on the 2008t machine.It was reported the patient completed treatment without experiencing an adverse event, serious injury, or requiring medical intervention.Additional information was obtained during follow-up with the biomed and a user facility nurse.The nurse clarified that the issue resulted from operator error.The staff member who programmed the patient¿s treatment typed 300 ml instead of 3000 ml as the intended ultrafiltration (uf) goal.The error was not noted until treatment completion when the patient pulled the programmed 300 ml.The patient did not experience any symptoms or adverse events as a result of the reported issue.The patient returned to the clinic on a different day for an additional treatment to remove the fluid that was not taken in the original treatment.The biomed stated that the machine was removed from service for testing following the reported event.A simulated ultrafiltration (uf) treatment was completed without issue.No issues were identified and no parts were replaced.The machine has been released for service.No samples will be returned to the manufacturer for physical evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
2008T HEMODIALYSIS SYS., WITH CDX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key19136240
MDR Text Key340565886
Report Number0002937457-2024-00642
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100897
UDI-Public00840861100897
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 05/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number190713
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 04/11/2024
Initial Date FDA Received04/18/2024
Supplement Dates Manufacturer Received05/22/2024
Supplement Dates FDA Received05/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/04/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient SexFemale
Patient Weight91 KG
-
-